Objectives: To examine the safety, efficacy, and efficiency of the PlasmaWire TM System to recanalize coronary chronic total occlusions (CTO) using controlled ablation inside the CTO.
| I N TR ODU C TI ON
Although increasing operator experience, refined devices, and the emergence of new techniques have improved the success rate of PCI of CTO [1] [2] [3] [4] [5] [6] , no new CTO devices have been proven to significantly improve the success rate of CTO PCI as compared to mechanical CTO wires. Radiofrequency (RF) wires have been studied for around 30 years [7] and some have been commercially available primarily for coronary and/or peripheral use (Safe-Cross TM Wire, Intraluminal Therapeutics [8, 9] , San Diego, California; PowerWire TM , Baylis Medical
Company [10] , Montreal, Canada), however, these wires relied on a monopolar approach, requiring an external electrode for their return path, thereby limiting their ability to instantaneously create channels without causing thermal damage and to localize the ablated area.
Recently, a novel bipolar RF wire system, PlasmaWire TM System (RetroVascular, Pleasanton, CA), was developed which creates a plasma to facilitate plaque ablation and creates a channel inside a CTO (by localized and directional plasma between the coupled RF wire tips), with minimal thermal injury.
This is a first report on the initial results of the first-in-human (FIH) study of the PlasmaWire TM System applied for treatment of coronary CTOs.
| M E TH ODS

| Study design and population
The study was a prospective, nonrandomized, single-arm, multicenter study. Among patients with coronary CTOs listed as a clinical candidate for PCI in three hospitals, patients in who wire crossing failed despite a 10-min attempt with conventional mechanical wires and in which the CTO exit was still visible on angiogram after the failed attempt, were eligible for the study.
The inclusion criteria were as follows: eligible for stenting or CABG, TIMI flow 0, occlusion duration >3 months or unknown, reference vessel diameter >2.5 mm (visual), total occlusion length >10 mm or no excessive bend (>908) proximal to CTO. The exclusion criteria were as follows: contraindication for use of heparin, intolerance to dual antiplatelet therapy, abnormal CPK elevation or acute myocardial infarction (AMI), bleeding disorders, major bleeding or stroke within 6 months, deep-vein thrombosis, LVEF < 30%, coronary aneurysm adjacent to targeted CTO or other life-threatening disease. The study protocol was approved by the ethics committee of the three hospitals and all patients signed informed consent before the procedure.
| Device description and technical details of use
The PlasmaWire TM System consists of three primary components: (1)
RF Generator (RFG), and (3) Connector Cable. The 0.014-in. PlasmaWire TM has a polymer insulation along its entire 190-cm length and an exposed distal tip ( Figure 1A ) and proximal end. The wire structure is innovatively designed as a CTO wire (tip load: 3.0 g) to perform and handle similar to Gaia 2nd wire (Asahi Intecc, Nagoya, Japan) by incorporating a novel rope coil technology. The custom RFG 
| Study endpoints and definitions
The primary endpoint of this FIH study was to demonstrate the effectiveness of this novel bi-polar RF wire system in making antegrade or retrograde re-entry for CTO recanalization as well as to report on the safety of this device.
Antegrade or retrograde re-entry was achieved with mechanical channel creation. While electrical channel creation was detected by the RFG algorithm, mechanical channel creation was confirmed by IVUS, tip injection, and/or crossing of the re-entry channel with an extrafloppy wire as described above. Patient success was defined as successful recanalization (residual stenosis < 30%, TIMI flow 2) without MACCE. To examine the device safety, ECG was continuously recorded to detect arrhythmia induced by RF activation, and vessel injury at the ablation site such as vessel perforation and significant dissection with hematoma was checked by IVUS and angiography. Before stenting, distal embolism potentially induced by microbubble generation with RF activation was also checked by angiography.
Other technical details such as delivered energy, elapsed RF activation time until channel creation, and procedure time from delivery of PlasmaWire TM to wire crossing were examined.
The patients were clinically followed for 1 month to check MACCE.
| Quantitative coronary angiography
Coronary angiograms were analyzed using a validated edge detection system (QAngioXA Ver.7.3.38.0, Medis medical imaging systems, Leiden, Netherlands). 
| R E SU LTS
Eligible patients were screened from October to December in 2015 and the FIH study was carried out in the same period. The patients were highly selected so that mechanical channel creation could be proven on angiography and/or IVUS. Consequently, seven patients (7 CTOs) were enrolled in this study. Clinical and target lesion characteristics are shown in Table 1 , in which all patients were male and the frequent comorbidities were old myocardial infarction (71.4%), hypertension (71.4%), dyslipidemia (57.1%), and diabetes (57.1%) while post-bypass surgery and peripheral artery disease were rare (0%, 14.3%). Two of 7 targeted CTOs (28.6%) were previously attempted but failed. While blunt stump at CTO entry was 28.6%, heavy calcified CTO and long CTO (>20 mm) were frequent (57.1%, 71.4%). Two of 7
CTOs were old in-stent proliferative occlusion. Bifurcation at CTO exit was found in 4 of 7 CTOs (57.1%).
In Table 2 In Table 3 , the results of plasma-mediated ablation are shown in each case. Electrical channel creation was detected by RFG algorithm in all cases.
Mechanical channel creation was checked by wire crossing in all cases, IVUS in six cases and tip injection in three cases although the created channel was checked with IVUS after use of Rotablator due to extremely heavy calcium in case TH. The typical IVUS findings of created channel in case KY are shown in Figure 3 . All cases were successfully recanalized through the created channel and stented except case KN in which the extra-floppy wire which initially crossed the channel was accidentally withdrawn and recrossing through the channel failed. Case FK is shown as a typical antegrade re-entry case in Figure 4 . In this case, a recanalization channel with smooth contour was created with a very short single RF activation (0.4 sec) using very low energy (0.42 joules) as shown in Figure 4D . In single RF activation cases, wire crossing was quickly achieved with a mean elapsed time from PlasmaWire TM delivery to wire crossing of 14 6 3 min (range 10-18 min). However, wire crossing was difficult in case KY which required repeated channel creation (three times) in order to achieve retrograde re-entry because the course of these three channels was zigzag in nature. Also in case of TH, repeated channel creation (three times) was needed for penetrating heavy calcium. Positioning the tip of the PlasmaWire TM for ablation was difficult in this case and consequently wire crossing took 54 min.
Patient success was achieved in all cases without MACCE at 1 month or any minor complications related to RF activation such as vessel perforation, thrombosis, distal embolism and arrhythmia.
| D I SCUSSION
The present study illustrated the feasibility and safety of the PlasmaWire TM System for channel creation in CTOs. The benefit of this device over conventional mechanical wires is considered to be its ability to efficiently create a channel without utilizing mechanical force which may minimize the chance of creating false channels. Therefore, it is anticipated that even in situations in which tissue penetration for re-entry is difficult with a mechanical wire due to subintimal dissections created around the distal true lumen, this novel RF wire system may reliably allow re-entry through channel creation. This is supported by the fact that both antegrade and retrograde re-entry was successfully achieved in all cases. Additionally, when utilizing this device, further expansion of the dissection is unnecessary for making re-entry unlike the Stingray TM System [11] (Boston Scientific, Marlborough, MA).
Compared to previous RF wires, the PlasmaWire TM possesses
properties very similar to mechanical CTO wires by incorporating the latest CTO wire technology. Unlike RF monopolar systems, the direction and ablation area can be more precisely controlled. So even if both wires are subintimal there is little risk of vessel perforation. In the bipolar system, wire advancement during RF activation is unnecessary for creating a channel within a predetermined length (<2.0 mm) because the channel is always created in the tissue between both wire tips.
Obviously wire advancement during ablation may increase the risk of vessel perforation. In the present study, the tip of this wire was well controlled and vessel perforation was not observed as a result of plasma-mediated ablation in all cases. Additionally, the bipolar After the extra-floppy wire crossed the CTO through the created channel, the wire was accidentally withdrawn and re-crossing was failed. Therefore, the CTO was recanalized with reverse CART technique [4] . c Success was obtained by additional activations after failed activations (two times).
CTO: chronic total occlusion, PW*: PlasmaWire TM.
arrangement allows use of higher energy between both wire tips as compared to monopolar arrangement and can more efficiently create channels [12] . In most of the FIH cases, the energy delivered to create a channel was <2.0 J (range 0.42-2.30 J) and the channels were created within 2 sec with single RF activation in all but two cases. For safety and more efficient channel creation, the gap between both wire tips was targeted to be within 2.0 mm in the present study based on the results of bench tests and animal studies. However, this seems to depend on the characteristics of the tissue between the wire tips. In fact, a channel was safely created with a gap >3.0 mm in two cases, while a shorter gap might be required for successful channel creation in heavily calcified tissue.
Although the mechanism of ablation using conventional RF wires is considered to be Joule heating, cellular vaporization and cavitation [7, 13] , as well as other mechanisms such as shock wave by plasma discharge (pulsed spark) [14] is suggested in the PlasmaWire TM System based on confirmation of shock wave generation in bench tests, minimum to no thermal injury in bench tests and animal studies, and channel creation in bone ( Figure 2 ) and in heavy calcium as shown in this study. However, based on the present study, it appears that certain conditions, such as electrical characteristics of tissue to be ablated (e.g., impedance, phase angle) and extent of contact between the wire tip and the tissue, likely play a role in successfully creating a channel and still need to be better defined.
Further clinical studies are necessary to clarify the clinical effectiveness and limitations of the PlasmaWire TM System. For example, the mean elapsed time from PlasmaWire TM delivery to wire crossing after ablation in this study was short in cases with single RF activation because the utilization of this device in those cases involved simply making a re-entry at the proximal or distal end of CTO. However, when this device is used for channel creation within the CTO body, multiple RF activations might be required for making a recanalization channel and it might take time for wire crossing. Therefore, how to efficiently apply this device for CTO crossing should be studied.
| C ONC LUSI ON S
In the present study, the PlasmaWire TM System was shown to facilitate CTO crossing with channel creation safely and effectively with low 
